Author name: Mike M.

german-startup-secures-funding-for-bizarre-twisted-fusion-machine

German startup secures funding for bizarre twisted fusion machine

German startup secures funding for bizarre twisted fusion machine

Siôn Geschwindt

Story by

Siôn Geschwindt

A German startup has secured its first investment to scale a bizarre twisted-looking fusion machine that could power the world with abundant, clean, and limitless energy.   

Proxima Fusion raised €‎7mn in funding to build a device known as a stellarator, a little-known fusion reactor that could hold the key to unlocking the potential of atom-fusing power within our lifetime.  

While the initial funding round was small, it is noteworthy because the startup is the first spinout from Germany’s esteemed Max Planck Institute for Plasma Physics.  

The institute is solely dedicated to fusion research and is home to the world’s largest stellarator. Dubbed the Wendelstein 7-X, the machine is the result of 27 years of research and design (and €‎1.3bn of investment), aided by recent advancements in supercomputing and state-of-the-art plasma theory. 

german-startup-fusion-energy
Wendelstein 7-X — this heap of metal, pipes, and plasma could be the energy plant of the future. Credit: Max Plank Institute/Jan Hosan

While the physics behind the machine is extremely complicated, what matters is that stellarators offer a number of potential advantages to the more popular doughnut-shaped tokamak — a design that has dominated the fusion sector for decades.  

The twisted configuration of the superconducting magnets in a stellarator help to keep the super-heated plasma they contain stable enough to fuse nuclei and release energy. Even more crucial for a future fusion power plant, they can theoretically operate continuously, whereas tokamaks must stop periodically to reset their magnet coils. 

However, stellarators are notoriously complex to design and build, which is why they were largely set aside in the 1960s in favour of their simpler cousin, the tokamak. 

“A tokamak is kind of easy to design, hard to operate, whereas a stellarator is super hard to design but once you’ve designed it, it’s way easier to operate,” Ian Hogarth, co-founder of Plural Platform, which is leading the €7mn investment, told the Financial Times.

Since the German Chancellor at the time, Angela Merkel, turned on W7-X in 2016, it has achieved a number of scientific breakthroughs that are “basically defining the whole field of magnetic confinement fusion,” said Hogarth.  

Fusion physicist Josefine Proll of the Eindhoven University of Technology is equally excited. “All of a sudden, stellarators are back in the game,” she said

Proxima Fusion, aided by the initial investment, looks to take these developments commercial. Its CEO Francesco Sciortino believes that the startup’s connection to the Max Planck Institute, which has more people working on plasma physics than MIT, offers a unique advantage. “The question is, can we execute just as well, and really make this a European champion?” he asked. 

While private investment has poured into tokamak pioneers — such as the likes of MIT spinout CFS, valued at over $2bn — recent breakthroughs in stellarator technology could pave the way for a new cohort of fusion startups like Proxima. 

Type One, a spinoff from the University of Wisconsin-Madison, and Proxima’s only other competitor so far, raised $29mn in March from Bill Gates’ Breakthrough Ventures to develop a commercially viable stellarator. 

While the stellarator startup scene is powering up, Thomas Klinger, director of the Max Planck Institute’s Greifswald branch, cautioned that commercially viable operations could still be 25 years away. 

However, if the technology can deliver on the promise of limitless, clean energy — then it’s probably worth the wait. 

If you, like me, would really like to nerd out on stellarator technology a bit more, check out this fascinating explainer from the Max Planck Institute:

The trailer outlines some of the game’s fundamental mechanics, including the ability to quickly navigate the environment by swinging around on chains like a steam-punk Spider-Man. The trailer also shows how weapon upgrades will work, and teases an interesting dual-wielding reloading mechanic that we’re curious to learn more about.

Alongside the release of the gameplay overview, Joy Way announced Dead Hook will now release on June 29th, a little more than a month after it’s previously announced May 18th release date.

The studio actually claims it’s still on track for the original release date, but delayed the game due to “important business reasons, including unforeseen changes in the Meta release calendar.”

While there’s not much of an explanation beyond that, most likely it’s related to the recently announced Meta Quest Gaming Showcase that’s happening on June 1st.

In any case, Joy Way says it will use the additional time for “extra polish and finishing touches, as well as incorporating content that was planned for after the release.”

Run & Gun Roguelike ‘Dead Hook’ Gets New Gameplay Trailer Alongside Delayed Quest Release Date Read More »

biohack-me,-baby:-why-i-can’t-wait-for-teemu-arina’s-talk-at-tnw-conference

Biohack me, baby: Why I can’t wait for Teemu Arina’s talk at TNW Conference

Biohack me, baby: Why I can’t wait for Teemu Arina’s talk at TNW Conference

Thomas Macaulay

Story by

Thomas Macaulay

Senior reporter

Thomas is a senior reporter at TNW. He covers European tech, with a focus on deeptech, startups, and government policy. Thomas is a senior reporter at TNW. He covers European tech, with a focus on deeptech, startups, and government policy.

Teemu Arina will be speaking at TNW Conference, which takes place on June 15 & 16 in Amsterdam. If you want to experience the event (and say hi to our editorial team!), we’ve got something special for our loyal readers. Use the promo code READ-TNW-25 and get a 25% discount on your business pass for TNW Conference. See you in Amsterdam!

I often fantasise about biohacking my useless brain. At TNW Conference, my dreams could finally be fulfilled.

On day two of the event, biohacker Teemu Arina will immerse attendees in the fascinating realm of human enhancement.

Arina is one of the world’s leading authorities on the movement. He co-authored the bestselling Biohacker’s Handbook and founded the Biohacker Summit — Europe’s leading conference for optimising human performance. He’s also the co-founder of Biohacker Center, an independent think tank that researches peak performance, health, and well-being.

Naturally, Arina meticulously biohacks himself. Initially, I imagined this would involve drilling brain chips into his skull. But biohacking is closer to DIY biology.

Arina’s website provides a more detailed description:

“Biohacking is the art and science of optimizing your body, mind, and performance with systems thinking, technology, and biology — in other words, better living through science.”

Arina entered the field after he was afflicted by a chronic illness. Biohacking provided a route to recovery. That led him to further optimise his health and performance with biological and technological tools.

Some of these tools are surprisingly accessible. Arina uses activity trackers to manage stress, a headset to measure brainwaves, a muscle scanner to guide fitness training, and a blue light device to synchronise his circadian rhythm.

At TNW Conference on June 16, Arina will unravel the next phase of biohacking — and how it can unlock human potential. He promises to share his pioneering techniques for enhancing physical and mental performance.

To my decrepit mind and body, that sounds like an unmissable offer. And just in case Arina wants to ramp it up, I’m bringing my brain and scalpel.

Teemu Arina’s biohacking tips are merely one attraction of TNW Conference. You can find more on the event agenda — and remember: for a 25% discount on business passes, use the promo code READ-TNW-25.

Get the TNW newsletter

Get the most important tech news in your inbox each week.

Also tagged with


Biohack me, baby: Why I can’t wait for Teemu Arina’s talk at TNW Conference Read More »

browning-bananas-under-threat-as-philippines-approves-gene-edited-version

Browning bananas under threat as Philippines approves gene-edited version

Browning bananas under threat as Philippines approves gene-edited version

Thomas Macaulay

Story by

Thomas Macaulay

Senior reporter

Thomas is a senior reporter at TNW. He covers European tech, with a focus on deeptech, startups, and government policy. Thomas is a senior reporter at TNW. He covers European tech, with a focus on deeptech, startups, and government policy.

Overripe bananas could soon become a mere memory — in the Philippines, at least.

Tropic Biosciences, a startup in the UK, has tapped gene editing to banish the browning fruit — and mitigate the havoc that it’s wreaking.

Currently, over 60% of exported bananas go to waste before reaching consumers. According to Tropic, the non-browning version could cut food waste and CO2 emissions in supply chains by over 25%.  In terms of CO2 reduction, the impact is comparable to taking 2m passenger vehicles off the road every year.

For the Philippines, there’s a more urgent appeal. The country is the top producer and exporter of bananas in Southeast Asia, but it’s being ravaged by a devastating plant disease. Known as Panama TR4, the disease threatens 80% of global banana production — and there’s no cure.

Tropic may have a solution: gene-editing bananas to make them disease-resistant. Unsurprisingly, the Philippine government has welcomed the prospect.

In a press release issued last month, Tropic announced that Filipino officials have given the green light to the non-browning bananas. Under the country’s newly-defined gene-editing rules, the product can now be freely imported and propagated.

“The Philippines government has implemented a science-based, transparent, and efficient process for assessing the safety of gene-edited plants,” said Dr Ofir Meir, Tropic’s Chief Technology Officer.

“This is exactly the type of system that encourages companies like Tropic to invest in innovative technologies to develop sustainable solutions for Filipino farmers.”

Ofir Meir
Meir previously served as R&D director of the crop protection division of Evogene, a computational biology company based in Israel.

For Tropic, bananas are just the start. Using gene-editing tools including CRISPR and the proprietary GEiGS system, the company can change the DNA of multiple organisms. As well as delaying ripening in bananas, the startup has already reduced caffeine in coffee and increased the yield in rice.

The benefits could be vast. Tropic promises higher output, expanded shelf-life, improved disease resistance, reduced waste, and lowered CO2 emissions. The company says it can also cut costs for growers.

Investors have clearly recognised the potential. Last year, Tropic raised $35 million in a fresh funding round. The cash injection followed a $28.5 million Series B raise in June 2020.

Naturally, that splurge isn’t solely motivated by altruism. Blue Horizon, which led last year’s round, estimates that the total market for Tropic’s produce is worth over $400 billion.

Get the TNW newsletter

Get the most important tech news in your inbox each week.

Also tagged with


Browning bananas under threat as Philippines approves gene-edited version Read More »